| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2040114 | Cell Reports | 2016 | 12 Pages |
•SHP1 influences osteogenic differentiation of MSCs•SHP1 deficiency leads to severe osteoporosis•SHP1 affects osteogenesis through dephosphorylating GSK3β
SummaryOsteoblasts and adipocytes are derived from a common precursor, mesenchymal stem cells (MSCs). Alterations in the normal fate of differentiating MSCs are involved in the development of obesity and osteoporosis. Here, we report that viable motheaten (mev) mice, which are deficient in the SH2-domain-containing phosphatase-1 (SHP1), develop osteoporosis spontaneously. Consistently, MSCs from mev/mev mice exhibit significantly reduced osteogenic potential and greatly increased adipogenic potential. When MSCs were transplanted into nude mice, SHP1-deficient MSCs resulted in diminished bone formation compared with wild-type MSCs. SHP1 was found to bind to GSK3β and suppress its kinase activity by dephosphorylating pY216, thus resulting in β-catenin stabilization. Mice, in which SHP1 was deleted in MSCs using SHP1fl/flDermo1-cre, displayed significantly decreased bone mass and increased adipose tissue. Taken together, these results suggest a possible role for SHP1 in controlling tissue homeostasis through modulation of MSC differentiation via Wnt signaling regulation.
Graphical AbstractFigure optionsDownload full-size imageDownload as PowerPoint slide
